Categories: News

Dalrada Financial Corporation Appoints Tom Giles to Board of Directors

SAN DIEGO, Feb. 17, 2021 /PRNewswire/ — Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Tom Giles was appointed to Dalrada’s Board of Directors. Mr. Giles’ executive management leadership includes technology and healthcare industries with a focus on artificial intelligence (AI) and machine learning (ML) to reduce time and expense to market. Mr. Giles’ accomplishments include raising more than $200 million in capital for startups and venture funds in addition to building strategic partnerships with some of the largest global companies including IBM, GE, Accenture, T-Mobile, and DST. He has held industry lead and advisory roles in early-stage ventures and incubators.

Mr. Giles’ has raised $200 million in capital for startups and built partnerships with IBM, GE, Accenture, and T-Mobile.

Brian Bonar, CEO of Dalrada states, “We are extremely fortunate to have Mr. Giles join Dalrada’s Board. His guidance is focused furthering on Dalrada’s technology and clean energy initiatives. Aided by his industry experience and vast network of global contacts, Dalrada anticipates accelerated domestic and international growth in technology and clean energy sectors.”

During his career, Mr. Giles has aided more than 20 companies with building business plans, identifying customer targets, raising capital, creating corporate sponsorships, and hiring executive management and sales teams. He presides on multiple Boards in the technology sector. Mr. Giles holds a Business degree from San Diego State University.

Dalrada’s impressive Board of Directors continues to assemble world leaders with extensive backgrounds in science, engineering, technology, clean energy, sustainability, and healthcare. This group of proven industry leaders are collectively responsible for the creation and implementation of breakthrough health and wellness modalities, sustainable environment initiatives, and significant business advances worldwide. Their collective guidance aids with speed of implementation of Dalrada’s mission to solve real-world problems. Dalrada’s Board of Directors is now composed of:

For additional information, visit https://dalrada.com 

About Dalrada (DFCO)
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) solves real-world problems by producing innovation-focused and technologically centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The Company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, visit www.dalrada.com or call 1-858-283-1253.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K. 

View original content:http://www.prnewswire.com/news-releases/dalrada-financial-corporation-appoints-tom-giles-to-board-of-directors-301229795.html

SOURCE Dalrada Financial Corp.

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago